OXGN : Summary for MATEON THERAPEUTICS INC - Yahoo Finance

U.S. Markets closed
Loading...
Loading...
  • Benzinga6 months ago

    OXiGENE Gets Orphan Drug Status For Its CA4P To Treat Glioma

    OXiGENE, Inc. (Nasdaq: OXGN ) revealed the Food and Drug Administration has granted orphan drug status to its CA4P for the treatment of glioma. According to the company, the designation provided for seven ...

  • Benzinga8 months ago

    OXiGENE Spikes 13% Following Receipt Of Fast Track Designation

    Shares of OXiGENE Inc (NASDAQ: OXGN ), a nano-cap biopharmaceutical company that focuses on the treatment of cancer, spiked higher by 13 percent on Wednesday after the company announced that the U.S. Food ...

  • We're sorry this is all we were able to find about this topic.